Page last updated: 2024-10-26

ditercalinium and Di Guglielmo Disease

ditercalinium has been researched along with Di Guglielmo Disease in 2 studies

ditercalinium: structure given in first source; RN given refers to parent cpd

Research Excerpts

ExcerptRelevanceReference
"Ditercalinium (NSC 335153) is a novel 7H-pyridocarbazole dimer in which the two monomers are joined by a rigid bis(ethylpiperidinyl)-linking chain producing a molecule capable of bisintercalation into DNA with extremely high affinity."1.27Cytokinetic effects of bifunctional antitumor intercalator ditercalinium on Friend erythroleukemia cells. ( Bueti, C; Darzynkiewicz, Z; Melamed, MR; Traganos, F, 1987)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Traganos, F2
Bueti, C2
Kapuscinski, J1
Darzynkiewicz, Z2
Melamed, MR1

Other Studies

2 other studies available for ditercalinium and Di Guglielmo Disease

ArticleYear
The antitumor intercalating drug ditercalinium binds preferentially to RNA in Friend erythroleukemia cells.
    Leukemia, 1989, Volume: 3, Issue:7

    Topics: Acridine Orange; Animals; Antineoplastic Agents; Binding Sites; Binding, Competitive; Carbazoles; Ce

1989
Cytokinetic effects of bifunctional antitumor intercalator ditercalinium on Friend erythroleukemia cells.
    Leukemia, 1987, Volume: 1, Issue:5

    Topics: Animals; Antineoplastic Agents; Carbazoles; Cell Cycle; DNA, Neoplasm; Intercalating Agents; Leukemi

1987